Teladoc Health, Inc. (NYSE:TDOC) Expected to Earn Q3 2024 Earnings of ($0.23) Per Share

Teladoc Health, Inc. (NYSE:TDOC) – Leerink Partnrs cut their Q3 2024 earnings per share (EPS) estimates for shares of Teladoc Health in a report issued on Thursday, August 1st. Leerink Partnrs analyst M. Cherny now forecasts that the health services provider will post earnings of ($0.23) per share for the quarter, down from their prior estimate of ($0.17). The consensus estimate for Teladoc Health’s current full-year earnings is ($1.06) per share. Leerink Partnrs also issued estimates for Teladoc Health’s Q4 2024 earnings at ($0.15) EPS, FY2024 earnings at ($1.15) EPS, FY2025 earnings at ($0.97) EPS, FY2026 earnings at ($0.74) EPS and FY2027 earnings at ($0.56) EPS.

TDOC has been the subject of a number of other research reports. Canaccord Genuity Group decreased their target price on shares of Teladoc Health from $25.00 to $17.00 and set a “buy” rating for the company in a research report on Thursday, August 1st. Truist Financial decreased their price objective on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a research report on Friday, August 2nd. Stifel Nicolaus dropped their target price on shares of Teladoc Health from $16.00 to $9.00 and set a “hold” rating on the stock in a report on Thursday, August 1st. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a report on Thursday, August 1st. Finally, Barclays lowered their price objective on Teladoc Health from $20.00 to $10.00 and set an “overweight” rating for the company in a research report on Thursday, August 1st. Fourteen investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $13.56.

Teladoc Health Price Performance

Shares of TDOC opened at $7.49 on Monday. The business has a 50-day moving average of $9.73 and a 200-day moving average of $13.43. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.74. The company has a market capitalization of $1.27 billion, a price-to-earnings ratio of -5.31 and a beta of 0.93. Teladoc Health has a 1 year low of $7.31 and a 1 year high of $26.00.

Insiders Place Their Bets

In other news, insider Vidya Raman-Tangella sold 3,857 shares of the business’s stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $8.14, for a total transaction of $31,395.98. Following the completion of the sale, the insider now directly owns 33,667 shares of the company’s stock, valued at $274,049.38. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, insider Vidya Raman-Tangella sold 3,857 shares of the company’s stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $31,395.98. Following the completion of the sale, the insider now owns 33,667 shares in the company, valued at $274,049.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Laizer Kornwasser sold 10,879 shares of the firm’s stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $8.14, for a total value of $88,555.06. Following the transaction, the chief executive officer now owns 99,929 shares in the company, valued at $813,422.06. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 37,714 shares of company stock worth $358,714. Insiders own 0.95% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

Hedge funds and other institutional investors have recently modified their holdings of the business. ICA Group Wealth Management LLC purchased a new stake in shares of Teladoc Health during the fourth quarter valued at approximately $28,000. Signaturefd LLC increased its position in shares of Teladoc Health by 148.7% during the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock valued at $28,000 after purchasing an additional 1,715 shares during the last quarter. International Assets Investment Management LLC bought a new stake in shares of Teladoc Health during the 2nd quarter worth $29,000. Hexagon Capital Partners LLC boosted its holdings in shares of Teladoc Health by 204.4% in the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after buying an additional 1,065 shares during the last quarter. Finally, RIA Advisory Group LLC bought a new position in Teladoc Health during the fourth quarter valued at about $36,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.